GDE1 Antibodies

Santa Cruz Biotechnology provides a broad selection of GDE1 monoclonal antibodies for investigating GDE1 in various biological processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GDE1, or glycerophosphodiester phosphodiesterase 1, is an essential enzyme involved in the metabolism of glycerophospholipids, playing a crucial role in cellular signaling and membrane dynamics. The enzyme's function is vital for maintaining cellular homeostasis and has implications in various physiological and pathological processes, including neurodegeneration and cancer. Research has shown that GDE1 activity influences multiple cellular pathways and signaling cascades. Understanding GDE1 regulation and function can provide valuable insights into its potential as a therapeutic target. Investigating GDE1 expression patterns helps reveal its role in different tissue types and developmental stages. Current research continues to uncover new aspects of GDE1 biology and its involvement in disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of GDE1's role in health and disease.